We are leaders in providing comprehensive support and assistance for the research, development, and regulation of ophthalmic products.
Years of Experience
Patents
Studies
It was founded by Professor Jesús Pintor in 2006 as a Spin-Off within the Complutense University of Madrid after winning the first prize in the “II IDEA COMPETITION FOR RESEARCHER SPIN-OFFS”.
The close relationship with the Complutense University of Madrid has always fostered and facilitated a research environment adapted to the latest technologies.
The technical department provides advice for both the design and development of new products, as well as studies tailored to market needs.
As a result of this work, the following products have been developed and brought to market:
Ocupharm Diagnostics offers a wide catalog of instrumental techniques capable of meeting the most varied scientific needs, providing a comprehensive service to our clients.
Our commitment to innovation is reflected in our numerous patents.
These products have been developed based on pioneering research in our R&D department. Currently, we have leading patents in the diagnosis of Acanthamoeba, dry eye, delivery, and enhancement of ophthalmic drug administration, as well as dietary supplements.
Composed of professors, researchers, and doctoral students from various Departments and Teaching Units of the Faculty of Optics and Optometry at the Complutense University of Madrid.
We provide a comprehensive service to our clients that includes the design and development of clinical studies, clinical and basic experimentation, “legacy device” regulatory studies, new product development, technical dossier preparation, offering help and advice for any need that our clients might have related to ophthalmic products.
To help companies design new ophthalmic products and promote the training of highly specialized professionals in the ophthalmic sector.
To advise and collaborate with both public and private companies in the development of new products and the adaptation of existing products to ensure compliance with the new EU Medical Devices Regulation (MDR).
